Profile of quizartinib for the treatment of adult patients with relapsed/refractory FLT3-ITD-positive acute myeloid leukemia: Evidence to date

Luke Fletcher, Sunil K. Joshi, Elie Traer

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Profile of quizartinib for the treatment of adult patients with relapsed/refractory FLT3-ITD-positive acute myeloid leukemia: Evidence to date'. Together they form a unique fingerprint.

Medicine & Life Sciences